Exai Bio

A liquid biopsy company using orphan non-coding RNA biomarkers and AI to detect and characterize cancer from a routine blood draw.

Location: Palo Alto, United States

1 model(1 RNA, 1 Language model)

Models (1)

Exai Bio / UCSF / Arc Institute / University of California, Davis

Released March 26, 2025

———

Cell-free RNA language model for liquid biopsy, fusing RNA sequence embeddings with cfRNA abundance across 306 billion pretraining tokens.

RNALanguage model